tiprankstipranks
Advertisement
Advertisement

AU:AFP Stock Latest News

AFT Pharmaceuticals Lifts Total Dividend for FY2026
Company AnnouncementsAFT Pharmaceuticals Lifts Total Dividend for FY2026
6d ago
AFT Pharmaceuticals Sets July Date and Nomination Deadline for 2026 AGM
PremiumCompany Announcements
AFT Pharmaceuticals Sets July Date and Nomination Deadline for 2026 AGM
7d ago
AFT Pharmaceuticals Grants New Performance-Linked Employee Share Options
PremiumCompany Announcements
AFT Pharmaceuticals Grants New Performance-Linked Employee Share Options
10d ago
AFT Pharmaceuticals posts record profit on global expansion and R&D push
PremiumCompany Announcements
AFT Pharmaceuticals posts record profit on global expansion and R&D push
11d ago
AFT Pharmaceuticals Declares Fully Imputed FY26 Final Dividend
PremiumCompany Announcements
AFT Pharmaceuticals Declares Fully Imputed FY26 Final Dividend
11d ago
AFT Pharmaceuticals appoints new CFO to support global growth
PremiumCompany AnnouncementsAFT Pharmaceuticals appoints new CFO to support global growth
14d ago
AFT Pharmaceuticals schedules FY2026 results release and investor webcast
Premium
Company Announcements
AFT Pharmaceuticals schedules FY2026 results release and investor webcast
20d ago
AFT Pharmaceuticals sets 21 May date for FY2026 results and investor webinar
Premium
Company Announcements
AFT Pharmaceuticals sets 21 May date for FY2026 results and investor webinar
24d ago
AFT Pharmaceuticals posts record growth and strikes key U.S. distribution deal
PremiumCompany Announcements
AFT Pharmaceuticals posts record growth and strikes key U.S. distribution deal
2M ago
AFT Pharmaceuticals faces change in CFO succession plan
PremiumCompany Announcements
AFT Pharmaceuticals faces change in CFO succession plan
2M ago
AFT Pharmaceuticals Wins Appeal in Pascomer Profit-Sharing Dispute
PremiumCompany Announcements
AFT Pharmaceuticals Wins Appeal in Pascomer Profit-Sharing Dispute
3M ago
AFT Pharmaceuticals Targets Niche Dermatology Upside With New Rapamycin Port Wine Stain Trial
PremiumCompany Announcements
AFT Pharmaceuticals Targets Niche Dermatology Upside With New Rapamycin Port Wine Stain Trial
3M ago
AFP
AFT Pharmaceuticals accelerates global hospital push and targets US$6bn injectable market with new R&D deal
PremiumCompany AnnouncementsAFT Pharmaceuticals accelerates global hospital push and targets US$6bn injectable market with new R&D deal
5M ago
AFP
AFT Pharmaceuticals Releases 1H 2026 Performance Overview
Premium
Company Announcements
AFT Pharmaceuticals Releases 1H 2026 Performance Overview
6M ago
AFP
AFT Pharmaceuticals Releases Interim Report for H1 2025
Premium
Company Announcements
AFT Pharmaceuticals Releases Interim Report for H1 2025
6M ago
AFP
AFT Pharmaceuticals Achieves Record Revenue Growth in First Half of 2025
PremiumCompany Announcements
AFT Pharmaceuticals Achieves Record Revenue Growth in First Half of 2025
6M ago
AFP
AFT Pharmaceuticals Announces CFO Transition Amidst Global Expansion
PremiumCompany Announcements
AFT Pharmaceuticals Announces CFO Transition Amidst Global Expansion
6M ago
AFP
AFT Pharmaceuticals to Release Half-Year Interim Results on November 20, 2025
PremiumCompany Announcements
AFT Pharmaceuticals to Release Half-Year Interim Results on November 20, 2025
7M ago
AFP
AFT Pharmaceuticals Advances Towards $300 Million Revenue Target with Key Clinical Trial Success
PremiumCompany Announcements
AFT Pharmaceuticals Advances Towards $300 Million Revenue Target with Key Clinical Trial Success
8M ago
AFP
AFT Pharmaceuticals Director Increases Shareholding
PremiumCompany AnnouncementsAFT Pharmaceuticals Director Increases Shareholding
9M ago
AFP
AFT Pharmaceuticals Secures Shareholder Approval for Key Resolutions
Premium
Company Announcements
AFT Pharmaceuticals Secures Shareholder Approval for Key Resolutions
10M ago
AFP
AFT Pharmaceuticals Reports Strong Growth and Global Expansion
Premium
Company Announcements
AFT Pharmaceuticals Reports Strong Growth and Global Expansion
10M ago
AFP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >